½ÃÀ庸°í¼­
»óǰÄÚµå
1667194

ÀüÀÚó¹æÀü ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)

e-prescribing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 130 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÀüÀÚó¹æÀü ½ÃÀåÀº 2024³â 26¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ 22.6%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀå¿¡´Â µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ ºü¸¥ äÅÃ, ¿ø°ÝÀÇ·á¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Åõ¾à ½Ç¼ö ÃÖ¼ÒÈ­ ¹× ÀÇ·á »ç±â ¹æÁö¿¡ ´ëÇÑ °ü½É Áõ°¡°¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀüÀÚó¹æÀü ½Ã½ºÅÛÀº ó¹æÀü °ü¸®¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ ÀÇ·á ¼­ºñ½º Á¦°øÀÇ Á¤È®¼º, È¿À²¼º, ȯÀÚ ¾ÈÀü¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀÌ µðÁöÅÐ ÀüȯÀ» Á¡Á¡ ´õ ¿ì¼±¼øÀ§¿¡ µÎ°í ÀÖ´Â °¡¿îµ¥, Çõ½ÅÀûÀÎ ±â¼úÀÇ ÅëÇÕÀº Çö´ë ÀÇ·á ÇàÀ§ÀÇ Çʼö ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

e-prescribing Market-IMG1

ÀüÀÚó¹æÀü Ç÷§ÆûÀº ÀüÀڰǰ­±â·Ï(EHR)°úÀÇ ¿Ïº®ÇÑ ÅëÇÕÀ» ÅëÇØ ÀÇ·áÁøÀÌ º´·Â, ¾Ë·¹¸£±â, ÇöÀç º¹¿ë ÁßÀÎ ¾à¹° µî Á¾ÇÕÀûÀΠȯÀÚ µ¥ÀÌÅÍ¿¡ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÓ»óÀû ÀÇ»ç°áÁ¤À» Áö¿øÇϰí, ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϸç, ¾à¹° ºÎÀÛ¿ëÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ÀÇ·á ¼­ºñ½º Á¦°øÀÚ °£ÀÇ Çù¾÷À» °­È­ÇÏ¿© ȯÀÚ Ä¡·á¿¡¼­ ´õ ³ªÀº Çù¾÷À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î Á¤ºÎ¿Í ÀÇ·á ±â°üÀÌ µðÁöÅÐÈ­¿¡ ´ëÇÑ Á߿伺À» °­Á¶ÇÏ´Â °¡¿îµ¥, ÀüÀÚó¹æÀü ¼Ö·ç¼ÇÀº ÀÇ·á ÀÎÇÁ¶ó Çö´ëÈ­¿¡ ÇʼöÀûÀÎ ¿ªÇÒÀ» ÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ ±Ý¾× 26¾ï ´Þ·¯
¿¹»ó ±Ý¾× 195¾ï ´Þ·¯
CAGR 22.6%

¼Ö·ç¼Ç°ú ¼­ºñ½º·Î ºÐ·ùµÇ´Â ÀÌ ½ÃÀåÀº 2024³â ¼Ö·ç¼ÇÀÌ 68.9%ÀÇ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ÀÌ´Â °­·ÂÇÑ ¾à¹° °ü¸® µµ±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ó¹æÀü ¿À·ù¸¦ ÁÙÀ̱â À§ÇÑ ³ë·Â¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ÅëÇÕÇü°ú µ¶¸³Çü ¼Ö·ç¼ÇÀ¸·Î ³ª´µ¸ç, ÀÇ·á ¼­ºñ½º Á¦°øÀÚÀÇ ´Ù¾çÇÑ ¿ä±¸¿¡ ´ëÀÀÇÕ´Ï´Ù. ÅëÇÕÇü ¼Ö·ç¼ÇÀº Á¾ÇÕÀûÀÎ ±â´É°ú ±âÁ¸ ½Ã½ºÅÛ°úÀÇ »óÈ£¿î¿ë¼ºÀ» Á¦°øÇÑ´Ù´Â Á¡¿¡¼­ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¹Ý¸é, µ¶¸³Çü ¼Ö·ç¼ÇÀº ¼Ò±Ô¸ð Áø·á¼Ò³ª Ŭ¸®´ÐÀÇ Æ´»õ ¿ä±¸»çÇ×À» ÃæÁ·ÇÏ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

¼­ºñ½º ¶ÇÇÑ ½ÃÀåÀÇ Áß¿äÇÑ ±¸¼º¿ä¼Ò·Î, Áö¿ø, À¯Áöº¸¼ö, µµÀÔ, ³×Æ®¿öÅ·, ±³À° ¼­ºñ½º µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¼­ºñ½º´Â ÇコÄÉ¾î ºÎ¹®ÀÇ ¿ªµ¿ÀûÀÎ ¼ö¿ä¸¦ ÃæÁ·½ÃŰ¸é¼­ ÀüÀÚó¹æÀü ½Ã½ºÅÛÀÇ ¿øÈ°ÇÑ ±¸Ãà°ú ¿î¿µÀ» º¸ÀåÇÕ´Ï´Ù. ¼­ºñ½º Á¦°ø¾÷ü´Â Áö¼ÓÀûÀÎ ±â¼ú Áö¿ø°ú ½Ã½ºÅÛ ¾÷µ¥ÀÌÆ®¸¦ Á¦°øÇÔÀ¸·Î½á ÀÇ·á ±â°üÀÌ ÃÖÀûÀÇ ¼º´ÉÀ» À¯ÁöÇÏ°í º¯È­ÇÏ´Â ±ÔÁ¤À» ÁؼöÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.

Àü°³¸¦ ±âÁØÀ¸·Î º¼ ¶§, ½ÃÀå¿¡´Â À¥ ¹× Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç°ú ¿ÂÇÁ·¹¹Ì½º ½Ã½ºÅÛÀÌ Æ÷ÇԵǸç, À¥ ¹× Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀº Àú·ÅÇÑ °¡°Ý, È®À强 ¹× »ç¿ë ÆíÀǼºÀ» ¹Ý¿µÇÏ¿© 2024³â 69.4%ÀÇ ½ÃÀå Á¡À¯À²·Î ¿ìÀ§¸¦ Â÷ÁöÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº °í°¡ÀÇ Çϵå¿þ¾î³ª ÀÎÇÁ¶ó¸¦ ÇÊ¿ä·Î ÇÏÁö ¾Ê±â ¶§¹®¿¡ Áß¼Ò±Ô¸ðÀÇ Áø·á¼Ò¿¡ ƯÈ÷ ¸Å·ÂÀûÀÔ´Ï´Ù. »óÈ£ ¿î¿ë¼º°ú ¿ø°Ý ¾×¼¼½º ±â´ÉÀ» ÅëÇØ ÀÇ·á ¼­ºñ½º Á¦°øÀڴ ȯÀÚÀÇ ¾ÈÀü°ú ¸¸Á·µµ¸¦ ³ôÀ̸鼭 ó¹æÀüÀ» È¿À²ÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¹Ì±¹Àº 2024³â 9¾ï 5,030¸¸ ´Þ·¯ÀÇ ½ÃÀåÀ» âÃâÇßÀ¸¸ç, ÀÌ´Â ÇコÄɾîÀÇ µðÁöÅÐÈ­¸¦ ÃËÁøÇÏ´Â ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¿¬¹æ Á¤ºÎÀÇ Àǹ«È­¿Í ÀçÁ¤Àû Àμ¾Æ¼ºê°¡ EHR ¹× ÀüÀÚó¹æÀü µµÀÔ¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖÀ¸¸ç, ¾ö°ÝÇÑ ±ÔÁ¤ Áؼö ¿ä°Ç°ú µ¥ÀÌÅÍ º¸¾È¿¡ ´ëÇÑ °­ÇÑ ÁýÂøÀÌ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç°ú AI ±â¹Ý µµ±¸ÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀüÀÚó¹æÀü ½ÃÀåÀº ¾à¹° °ü¸®¸¦ Çõ½ÅÇϰí ÀÇ·á ½Ã½ºÅÛ Àü¹Ý¿¡ °ÉÃÄ È¯ÀÚ Ä¡·á °á°ú¿Í ¾÷¹« È¿À²¼ºÀ» °³¼±ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • µðÁöÅÐ Çコ ¼Ö·ç¼Ç°ú ÀüÀÚÀǹ«±â·Ï ä¿ë È®´ë
      • ¿ø°ÝÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ÀÎ½Ä È®»ê
      • Åõ¾à ¹Ì½º Àý°¨¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
      • ÇコÄɾîÀÇ ºÎÁ¤À̳ª ³²¿ë Àý°¨¿¡ ´ëÇÑ °ü½É »ó½Â
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©¿Í °úÁ¦
      • ½Ã½ºÅÛ ÅëÇÕ°ú »óÈ£¿î¿ë¼º¿¡ °üÇÑ ±â¼úÀû °úÁ¦
      • µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿Í ¾ÈÀü¼º¿¡ °üÇÑ ¿ì·Á
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ±â¼úÀû Àü¸Á
  • ÇâÈÄ ½ÃÀå µ¿Çâ
  • Porters ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼Ò°³
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« Àü¸Á

Á¦5Àå ½ÃÀå ÃßÁ¤°ú ¿¹Ãø : À¯Çüº°, 2021-2034³â

  • ÁÖ¿ä µ¿Çâ
  • ¼Ö·ç¼Ç
    • ÅëÇÕ ¼Ö·ç¼Ç
    • µ¶¸³Çü ¼Ö·ç¼Ç
  • ¼­ºñ½º
    • Áö¿ø ¹× À¯Áöº¸¼ö ¼­ºñ½º
    • ±¸Çö ¼­ºñ½º
    • ³×Æ®¿öÅ© ¼­ºñ½º
    • Æ®·¹ÀÌ´× ¹× ±³À° ¼­ºñ½º

Á¦6Àå ½ÃÀå ÃßÁ¤°ú ¿¹Ãø : Àü°³ ¹æ½Äº°, 2021-2034³â

  • ÁÖ¿ä µ¿Çâ
  • À¥ ¹× Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç
  • ¿ÂÇÁ·¹¹Ì½º ¼Ö·ç¼Ç

Á¦7Àå ½ÃÀå ÃßÁ¤°ú ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021-2034³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • ±Ù¹«ÀÇ
  • ¾à±¹

Á¦8Àå ½ÃÀå ÃßÁ¤°ú ¿¹Ãø : Áö¿ªº°, 2021-2034³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®

Á¦9Àå ±â¾÷ °³¿ä

  • AdvancedMD
  • athenahealth
  • CompuGroup Medical
  • DrFirst.com
  • eClinicalWorks
  • Epic Systems Corporation
  • GE Healthcare
  • Greenway Health
  • Henry Schein
  • McKesson Corporation
  • Medical Information Technology
  • NextGen Healthcare
  • Oracle Corporation
  • Surescripts
  • Veradigm
ksm 25.04.08

The Global E-Prescribing Market, valued at USD 2.6 billion in 2024, is projected to expand at a CAGR of 22.6% between 2025 and 2034. This growth is fueled by the rapid adoption of digital health solutions, increasing awareness of telemedicine, and a heightened focus on minimizing medication errors and preventing healthcare fraud. E-prescribing systems are revolutionizing prescription management, enhancing accuracy, efficiency, and patient safety in healthcare delivery. As healthcare providers increasingly prioritize digital transformation, the integration of innovative technologies is becoming a critical component of modern medical practices.

e-prescribing Market - IMG1

E-prescribing platforms enable healthcare professionals to access comprehensive patient data, including medical history, allergies, and current medications, through seamless integration with electronic health records (EHRs). This integration supports informed clinical decision-making, streamlines workflows, and reduces the risk of adverse drug events. These systems also foster enhanced collaboration among providers, allowing for better coordination in patient care. With governments and healthcare organizations globally emphasizing digitalization, e-prescribing solutions are poised to play an essential role in the modernization of healthcare infrastructure.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$2.6 Billion
Forecast Value$19.5 Billion
CAGR22.6%

The market is categorized into solutions and services. Solutions accounted for a significant 68.9% market share in 2024, driven by the growing demand for robust medication management tools and efforts to reduce prescription errors. These solutions are divided into integrated and standalone options, catering to the diverse needs of healthcare providers. Integrated solutions have become increasingly popular, offering comprehensive functionality and interoperability with existing systems. Meanwhile, standalone solutions address niche requirements for smaller practices and clinics.

Services also form a critical component of the market, encompassing support and maintenance, implementation, networking, and training services. These offerings ensure the smooth deployment and operation of e-prescribing systems while addressing the dynamic demands of the healthcare sector. By providing ongoing technical support and system updates, service providers help healthcare organizations maintain optimal performance and compliance with evolving regulations.

Based on deployment, the market includes web and cloud-based solutions and on-premise systems. Web and cloud-based solutions dominated with a 69.4% market share in 2024, reflecting their affordability, scalability, and ease of use. These solutions eliminate the need for costly hardware and infrastructure, making them particularly attractive to small and mid-sized practices. Their interoperability and remote access capabilities allow healthcare providers to manage prescriptions efficiently while enhancing patient safety and satisfaction.

The United States generated USD 950.3 million in 2024, driven by regulatory frameworks that promote healthcare digitalization. Federal mandates and financial incentives have accelerated the adoption of EHRs and e-prescribing systems, while strict compliance requirements and a strong focus on data security further bolster market growth. With the increasing use of cloud-based solutions and AI-powered tools, the e-prescribing market is set to transform medication management, ensuring improved patient outcomes and operational efficiency across healthcare systems.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing adoption of digital health solutions and electronic health records
      • 3.2.1.2 Increasing awareness towards telemedicine services
      • 3.2.1.3 Increasing demand for reducing medication errors
      • 3.2.1.4 Growing focus towards reducing healthcare fraud and abuse
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Technical challenges related to system integration and interoperability
      • 3.2.2.2 Concerns related to data privacy and safety
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Future market trends
  • 3.7 Porter’s analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy outlook

Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Solutions
    • 5.2.1 Integrated solutions
    • 5.2.2 Standalone solutions
  • 5.3 Services
    • 5.3.1 Support and maintenance services
    • 5.3.2 Implementation services
    • 5.3.3 Network services
    • 5.3.4 Training and education services

Chapter 6 Market Estimates and Forecast, By Deployment Mode, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Web and cloud-based solutions
  • 6.3 On-premise solutions

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Office-based physicians
  • 7.4 Pharmacies

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 AdvancedMD
  • 9.2 athenahealth
  • 9.3 CompuGroup Medical
  • 9.4 DrFirst.com
  • 9.5 eClinicalWorks
  • 9.6 Epic Systems Corporation
  • 9.7 GE Healthcare
  • 9.8 Greenway Health
  • 9.9 Henry Schein
  • 9.10 McKesson Corporation
  • 9.11 Medical Information Technology
  • 9.12 NextGen Healthcare
  • 9.13 Oracle Corporation
  • 9.14 Surescripts
  • 9.15 Veradigm
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦